ODI Pharma AB (publ) (NGM: ODI)
Sweden flag Sweden · Delayed Price · Currency is SEK
3.200
-0.100 (-3.03%)
At close: Nov 22, 2024

ODI Pharma AB Revenue

ODI Pharma AB had revenue of 251.30K SEK in the quarter ending September 30, 2024, a decrease of -52.42%. This brings the company's revenue in the last twelve months to 22.16M, up 3,332.30% year-over-year. In the fiscal year ending June 30, 2024, ODI Pharma AB had annual revenue of 22.45M with 15,996.09% growth.

Revenue (ttm)
22.16M
Revenue Growth
+3,332.30%
P/S Ratio
2.20
Revenue / Employee
22.16M
Employees
1
Market Cap
48.70M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jun 30, 202422.45M22.31M15,996.09%
Jun 30, 2023139.46K-173.48K-55.44%
Jun 30, 2022312.94K--
Jun 30, 2021---
Jun 30, 2020---
Jun 30, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition